Medexus Pharmaceuticals Inc. (MDP.TO)
CAD 2.76
(-1.43%)
CAD 2.76
(-1.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 113.05 Million | 108.09 Million | 76.7 Million | 79.66 Million | 52.43 Million | 25.36 Million |
| Cost of Revenue | 53.54 Million | 48.05 Million | 38.77 Million | 37.65 Million | 22.99 Million | 10.37 Million |
| Gross Profit | 59.51 Million | 60.03 Million | 37.92 Million | 42 Million | 29.44 Million | 14.98 Million |
| Operating Expenses | 46.72 Million | 51.54 Million | 50.3 Million | 41.27 Million | 30.48 Million | 15.66 Million |
| Selling, General and Administrative Expenses | 38.43 Million | 48.25 Million | 44.03 Million | 36.17 Million | 28.93 Million | 15.61 Million |
| Research and Development Expenses | 8.03 Million | 2.94 Million | 5.87 Million | 4.59 Million | 1.09 Million | - |
| Other Expenses | 251 Thousand | - | - | - | - | - |
| Cost and Expenses | 100.26 Million | 99.6 Million | 89.07 Million | 78.92 Million | 53.47 Million | 26.04 Million |
| Operating Income | 10.79 Million | 7.61 Million | -14.99 Million | -1.37 Million | -5.41 Million | -4.39 Million |
| Interest Expense | 13.36 Million | 13.6 Million | 12.22 Million | 9.81 Million | 6.44 Million | 2.9 Million |
| Income Tax Expense | 320 Thousand | -6.26 Million | -941 Thousand | -3.23 Million | -790.43 Thousand | 166.28 Thousand |
| Earnings before Tax | 106 Thousand | -5.04 Million | -3.82 Million | -31.5 Million | -5.18 Million | -4.71 Million |
| Net Income | -214 Thousand | 1.22 Million | -2.87 Million | -28.26 Million | -4.39 Million | -4.88 Million |
| Earnings Per Share Basic | -0.01 | 0.06 | -0.15 | -1.86 | -0.31 | -0.49 |
| Earnings Per Share Diluted | -0.01 | 0.06 | -0.14 | -1.86 | -0.31 | -0.49 |
| Weighted Average Shares Outstanding | 22.32 Million | 19.97 Million | 19.45 Million | 15.19 Million | 14.36 Million | 9.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.48 Million | 20.52 Million | 19.85 Million | 15.19 Million | 14.36 Million | 9.9 Million |
| Gross Margin | 0.53 | 0.56 | 0.49 | 0.53 | 0.56 | 0.59 |
| EBIT Margin | 0.17 | 0.13 | -0.08 | 0.08 | 0.03 | 0.06 |
| Profit Margin | -0.00 | 0.01 | -0.04 | -0.35 | -0.08 | -0.19 |
| EBITDA | 19.27 Million | 14.64 Million | 15.16 Million | -23.6 Million | 7.03 Million | 159 Thousand |
| Earnings Before Tax Margin | 0.10 | 0.07 | -0.20 | -0.02 | -0.10 | -0.17 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 27.28 Million | 25.96 Million | 113.05 Million | 25.21 Million | 30.32 Million | 31.55 Million |
| Cost of Revenue | 12.44 Million | 12.65 Million | 53.54 Million | 12.51 Million | 14.04 Million | 14.31 Million |
| Gross Profit | 14.83 Million | 13.3 Million | 59.51 Million | 12.69 Million | 16.27 Million | 17.23 Million |
| Operating Expenses | 10.5 Million | 10.48 Million | 46.72 Million | 11.12 Million | 12.72 Million | 12.39 Million |
| Selling, General and Administrative Expenses | 8.7 Million | 8.64 Million | - | 9.11 Million | 10.28 Million | 10.39 Million |
| Research and Development Expenses | 1.74 Million | 1.77 Million | - | 1.94 Million | 2.36 Million | 1.94 Million |
| Other Expenses | 59 Thousand | - | - | - | - | - |
| Cost and Expenses | 22.95 Million | 23.13 Million | 100.26 Million | 23.64 Million | 26.77 Million | 26.71 Million |
| Operating Income | 3.97 Million | 832 Thousand | 10.79 Million | 1.56 Million | 3.55 Million | 4.84 Million |
| Interest Expense | 2.03 Million | 2.22 Million | 13.36 Million | 2.65 Million | 4.22 Million | 4.25 Million |
| Income Tax Expense | -57 Thousand | 228 Thousand | 320 Thousand | -261 Thousand | 120 Thousand | 233 Thousand |
| Earnings before Tax | 1.9 Million | 990 Thousand | 106 Thousand | -795 Thousand | -973 Thousand | 884 Thousand |
| Net Income | 1.95 Million | 762 Thousand | -214 Thousand | -534 Thousand | -1.09 Million | 651 Thousand |
| Earnings Per Share Basic | 0.11 | 0.04 | - | -0.02 | -0.05 | 0.03 |
| Earnings Per Share Diluted | 0.11 | 0.04 | - | -0.02 | -0.05 | 0.03 |
| Weighted Average Shares Outstanding | 24.46 Million | 24.45 Million | 22.32 Million | 24.18 Million | 20.43 Million | 20.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.46 Million | 24.45 Million | 22.48 Million | 24.18 Million | 20.43 Million | 20.23 Million |
| Gross Margin | 0.54 | 0.51 | 0.53 | 0.50 | 0.54 | 0.55 |
| EBIT Margin | 0.21 | 0.16 | - | 0.12 | 0.17 | 0.20 |
| Profit Margin | 0.07 | 0.03 | -0.00 | -0.02 | -0.04 | 0.02 |
| EBITDA | 5.74 Million | 4.27 Million | - | 3.01 Million | 5.01 Million | 6.28 Million |
| Earnings Before Tax Margin | 0.15 | 0.03 | 0.10 | 0.06 | 0.12 | 0.15 |
BIOS
ELDN
EASTW-R
023000
002382
ACUS